Wide Ranks

ANIP

ANI Pharmaceuticals, Inc.

59.39

Top Statistics
Market Cap 1 B Forward PE 10.77 Revenue Growth 12.50 %
Current Ratio 2.75 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -1.28 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 20.25 Enterprise / Revenue 3.00 Price To Sales Trailing12 Months 2.25
Profitability
Profit Margins -1.28 % Operating Margins -7.34 %
Balance Sheet
Total Cash 153 M Total Cash Per Share 7.85 Total Debt 632 M
Total Debt To Equity 146.78 Current Ratio 2.75 Book Value Per Share 20.74
All Measures
Short Ratio 825.00 % Message Board Id finmb_1528824 Fax 218 634 3540
Shares Short Prior Month 2 M Return On Equity -0.0160 City Baudette
Uuid 75f2f385-f89c-3bd7-b1e1-58bda9a0aedf Previous Close 57.86 First Trade Date Epoch Utc 957 M
Book Value 20.74 Beta 0.7100 Total Debt 632 M
Volume 226391 Price To Book 2.86 Last Split Date 1 B
Fifty Two Week Low 48.20 Total Cash Per Share 7.85 Total Revenue 555 M
Shares Short Previous Month Date 1 B Target Median Price 83.00 Audit Risk 9
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -7.34 %
Target Mean Price 78.40 Net Income To Common -8766000 Short Percent Of Float 0.1301
Implied Shares Outstanding 21 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 245980 Average Volume10days 245980 Total Cash 153 M
Next Fiscal Year End 1 B Revenue Per Share 28.91 Held Percent Insiders 0.1112
Ebitda Margins 14.78 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Share Holder Rights Risk 1 Regular Market Previous Close 57.86
Target Low Price 62.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 58.29
Open 57.79 Free Cashflow 50 M State MN
Dividend Yield 0.00 % Return On Assets 0.0125 Time Zone Short Name EST
Board Risk 3 Trailing Eps -0.4700 Day Low 57.55
Address1 210 Main Street West Shares Outstanding 21 M Compensation Risk 3
Price Hint 2 Target High Price 94.00 Website https://www.anipharmaceuticals.com
52 Week Change 0.1923 Average Volume 309578 Forward Eps 5.53
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 184.10 %
Last Split Factor 1:6 Regular Market Day High 59.56 Is_sp_500 False
Profit Margins -1.28 % Debt To Equity 146.78 Fifty Two Week High 70.81
Day High 59.56 Shares Short 2 M Regular Market Open 57.79
Industry Key drug-manufacturers-specialty-generic Earnings Growth 0.00 % Enterprise To Revenue 3.00
Revenue Growth 12.50 % Shares Percent Shares Out 0.1004 Operating Cashflow 92 M
Currency USD Time Zone Full Name America/New_York Market Cap 1 B
Is_nasdaq_100 False Zip 56623 Quote Type EQUITY
Industry Drug Manufacturers - Specialty & Generic Long Name ANI Pharmaceuticals, Inc. Overall Risk 2
Regular Market Day Low 57.55 Held Percent Institutions 0.9968 Current Price 59.39
Enterprise To Ebitda 20.25 Financial Currency USD Current Ratio 2.75
Gross Margins 59.79 % Industry Disp Drug Manufacturers - Specialty & Generic Number Of Analyst Opinions 5
Country United States Float Shares 15 M Two Hundred Day Average 62.21
Governance Epoch Date 1 B Ir Website http://www.biosantepharma.com/SEC-Filings.php Price To Sales Trailing12 Months 2.25
Enterprise Value 1 B Forward PE 10.77 Regular Market Volume 226391
Ebitda 82 M Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.

The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products.

It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals.

ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.